Patents by Inventor Yan-Ruide Li

Yan-Ruide Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBATING COVID-19 USING ENGINEERED INKT CELLS
    Publication number: 20230323302
    Abstract: Aspects of the present disclosure relate to methods and compositions related to the preparation of immune cells, including engineered invariant natural killer T (iNKT) cells for off-the-shelf use for COVID-19 clinical therapy. The iNKT cells may be produced from hematopoietic stem progenitor cells and are suitable for allogeneic cellular therapy.
    Type: Application
    Filed: September 3, 2021
    Publication date: October 12, 2023
    Applicant: The Regents of the University of California
    Inventors: Lili Yang, Yan-Ruide Li
  • ENGINEERED OFF-THE-SHELF IMMUNE CELLS AND METHODS OF USE THEREOF
    Publication number: 20220257655
    Abstract: Aspects of the present disclosure relate to methods and compositions related to the preparation of immune cells, including engineered immune cells. Certain embodiments of the disclosure include compositions, cells, and methods related to engineered invariant natural killer T (iNKT) cells for off-the-shelf use for clinical therapy. The iNKT cells may be produced from hematopoietic stem progenitor cells and may be suitable for allogeneic cellular therapy because they are HLA negative. In some aspects, the cells have imaging and suicide targeting capabilities.
    Type: Application
    Filed: June 12, 2020
    Publication date: August 18, 2022
    Applicants: The Regents of the University of California, University of Southern California
    Inventors: Yu Jeong Kim, Yan-Ruide Li, Pin Wang, Lili Yang, Jiaji Yu